Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.
Int J Mol Sci. 2020 May 27;21(11):3779. doi: 10.3390/ijms21113779.
Nigrostriatal dopaminergic systems govern physiological functions related to locomotion, and their dysfunction leads to movement disorders, such as Parkinson's disease and dopa-responsive dystonia (Segawa disease). Previous studies revealed that expression of the gene encoding nigrostriatal tyrosine hydroxylase (TH), a rate-limiting enzyme of dopamine biosynthesis, is reduced in Parkinson's disease and dopa-responsive dystonia; however, the mechanism of TH depletion in these disorders remains unclear. In this article, we review the molecular mechanism underlying the neurodegeneration process in dopamine-containing neurons and focus on the novel degradation pathway of TH through the ubiquitin-proteasome system to advance our understanding of the etiology of Parkinson's disease and dopa-responsive dystonia. We also introduce the relation of α-synuclein propagation with the loss of TH protein in Parkinson's disease as well as anticipate therapeutic targets and early diagnosis of these diseases.
黑质纹状体多巴胺能系统支配与运动相关的生理功能,其功能障碍可导致运动障碍,如帕金森病和多巴反应性肌张力障碍(Segawa 病)。先前的研究表明,编码黑质纹状体酪氨酸羟化酶(TH)的基因表达减少,TH 是多巴胺生物合成的限速酶,在帕金森病和多巴反应性肌张力障碍中均有表达;然而,这些疾病中 TH 耗竭的机制尚不清楚。本文综述了含多巴胺神经元神经退行性变过程的分子机制,并重点介绍了通过泛素-蛋白酶体系统对 TH 进行的新型降解途径,以加深对帕金森病和多巴反应性肌张力障碍发病机制的认识。我们还介绍了帕金森病中 α-突触核蛋白传播与 TH 蛋白丢失的关系,并对这些疾病的治疗靶点和早期诊断进行了展望。